Hisamitsu Pharmaceutical Co. Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY229.85 |
Market Cap |
JPY370.34 B |
Shares Outstanding |
95.16 M |
Public Float |
37.87 M |
Address |
408 Tashiro Daikan-machi Tosu Saga 841 Japan |
Employees | - |
Website | http://www.hisamitsu.co.jp |
Updated | 07/08/2019 |
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, Lifecella, and Keplat brands. It also provides ethical pharmaceuticals, over the counter drugs, medical devices, health supplements, and topical analgesic products. |